Projects per year
Personal profile
Biography
Dr. Ekinci (MBBS FRACP PhD) is a clinician researcher. In April 2015, she commenced her role as the Sir Edward Dunlop Medical Research Foundation Senior Fellow in Metabolic Medicine at the University of Melbourne, Austin Health, relinquishing her NHMRC Early Career Fellowship. She is the Director of Diabetes at Austin Health where she co-ordinates the clinical care of inpatients and outpatients with diabetes.
She heads Diabetes and Obesity clinical trials at Austin Health and The University of Melbourne where she is Chief Investigator in numerous clinical trials. She is a Senior Research Fellow at the Menzies School of Health Research and Consultant Physician and a Research Fellow at BakerIDI. Dr Ekinci has been productive with 48 publications in the following journals: Diabetes Care, Diabetes, Diabetologia, Clinical Science, Diabetic Medicine, AJKD, Kidney International, MJA. She has co-authored more than 90 abstracts at various national and international meetings. She is currently supervising 4 PhD students and has supervised 16 Scholarly Selective students to completion at the University of Melbourne.
She is also responsible for mentoring endocrinologists, endocrine registrars, residents, interns, medical students and 10 clinical trials staff. She has obtained a total of $1.8 million of research funding including NHMRC Scholarship and an NHMRC Early Career Fellowship, Royal Australasian College of Physicians Fellowship, Australian Diabetes Society (ADS), Viertel Charitable Foundation Clinical Investigatorship, The University of Melbourne Early Career Research Grant, Sir Edward Weary Dunlop Medical Research Foundation and Diabetes Australia Research Trust project grants.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Austin Health
Charles Darwin University
Heidelberg Repatriation Hospital
University of Melbourne
Research area keywords
- Endocrinology
- Metabolic medicine
- Obesity & Diabetes
Network
-
Point of care detection of early kidney disease using infrared spectroscopy
Jandeleit-Dahm, K., Shaw, J., Brown, A. & Ekinci, E.
1/01/22 → 31/12/22
Project: Research
-
Point of care detection of early kidney disease using infrared spectroscopy
Jandeleit-Dahm, K., Wood, B., Cooper, M., Shaw, J., Brown, A. & Ekinci, E.
1/01/22 → 31/12/22
Project: Research
-
Post-stroke hyperglycaemia - Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial
Bladin, C., Cheung, N. W., Dewey, H., Churilov, L., Middleton, S., Thijs, V. & Ekinci, E.
1/01/17 → 30/06/22
Project: Research
-
Using dietary therapy to slow the progression of diabetic kidney disease
Snelson, M., Coughlan, M., Ekinci, E., Baqar, S., Muir, J. & Kellow, N.
3/05/21 → 31/12/21
Project: Research
-
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Snelson, M., de Pasquale, C., Ekinci, E. I. & Coughlan, M. T., May 2021, In: Best Practice & Research: Clinical Endocrinology & Metabolism. 35, 3, 13 p., 101507.Research output: Contribution to journal › Review Article › Other › peer-review
10 Citations (Scopus) -
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Trent, R. J., Poplawski, N. K., Martin, A. C., Srinivasan, S., Justo, R. N., Chow, C. K., Pang, J. & FH Australasia Network Consensus Working Group, 1 Mar 2021, In: Heart Lung and Circulation. 30, 3, p. P324-349 26 p.Research output: Contribution to journal › Letter › Other › peer-review
Open Access15 Citations (Scopus) -
The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors
Huang, W., Whitelaw, J., Kishore, K., Neto, A. S., Holmes, N. E., Marhoon, N., Bellomo, R. & Ekinci, E. I., Dec 2021, In: Journal of Diabetes and its Complications. 35, 12, 7 p., 108052.Research output: Contribution to journal › Article › Research › peer-review
-
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Reutens, A. T., Jandeleit-Dahm, K., Thomas, M., Salim, A., De Livera, A. M., Bach, L. A., Colman, P. G., Davis, T. M. E., Ekinci, E. I., Fulcher, G., Hamblin, P. S., Kotowicz, M. A., MacIsaac, R. J., Morbey, C., Simmons, D., Soldatos, G., Wittert, G., Wu, T., Cooper, M. E. & Shaw, J. E., Mar 2020, In: Contemporary Clinical Trials. 90, 8 p., 105892.Research output: Contribution to journal › Article › Other › peer-review
12 Citations (Scopus) -
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes
Curtin, F., Champion, B., Davoren, P., Duke, S., Ekinci, E. I., Gilfillan, C., Morbey, C., Nathow, T., O'Moore-Sullivan, T., O'Neal, D., Roberts, A., Stranks, S., Stuckey, B., Vora, P., Malpass, S., Lloyd, D., Maëstracci-Beard, N., Buffet, B., Kornmann, G., Bernard, C. & 2 others, , Jul 2020, In: Diabetes, Obesity and Metabolism. 22, 7, p. 1111-1121 11 p.Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus)